Corrigendum to “Correlating rrs and eis promoter mutations in clinical isolates of Mycobacterium tuberculosis with phenotypic susceptibility levels to the second-line injectables” [Int. J. Mycobacteriol. 5(1) 2016 1-6]. Go to Publication You Might Also Like Efficacy, safety and tolerability of linezolid containing regimens in treating MDR-TB and XDR-TB: systematic review and meta-analysis. April 10, 2012 Few eligible for the newly recommended short course MDR TB regimen at a large Mumbai private clinic. August 30, 2019 Neuropsychiatric reactions induced by cycloserine in the treatment of multidrug-resistant tuberculosis: what an Indian female patient tells us January 9, 2020 Determination of MICs of levofloxacin for Mycobacterium tuberculosis with gyrA mutations. October 19, 2015 Pneumocystis carinii pneumonia in HIV infected patients from Mumbai. May 16, 2005
Efficacy, safety and tolerability of linezolid containing regimens in treating MDR-TB and XDR-TB: systematic review and meta-analysis. April 10, 2012
Few eligible for the newly recommended short course MDR TB regimen at a large Mumbai private clinic. August 30, 2019
Neuropsychiatric reactions induced by cycloserine in the treatment of multidrug-resistant tuberculosis: what an Indian female patient tells us January 9, 2020
Determination of MICs of levofloxacin for Mycobacterium tuberculosis with gyrA mutations. October 19, 2015